Delaware Supreme Court upholds Fresenius/Akorn decision
Delaware’s highest state court has confirmed that healthcare company Fresenius was entitled to pull out of its multibillion-dollar acquisition of Akorn after finding that the generic drugmaker had misrepresented the state of its data.
To read more
Subscribe to Global Data Review
Subscribe and start reading now
The one-stop information source and community touchpoint, with coverage from across the areas of
- Data protection